The Defense Health Agency awarded Duke University a $3,811,150.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct a research project titled "SINGLE-CELL AND SPATIAL ANALYSIS OF LETHAL BREAST CANCERS". The grant period runs from April 1, 2024 to March 31, 2028. The key products and services to be delivered under this award include comprehensive single-cell and spatial analysis of breast cancer samples to characterize tumor heterogeneity and focal immune infiltration. This research aims to gain insights into the role of inflammation in breast cancer progression and metastasis. Duke University has also issued a $313,000 sub-award to the University of California, Davis to support this research effort.
Generated 12/10/24, 7:21 AM